KATSANOS, A. H., A. V. ALEXANDROV, P. MANDAVA, M. KOHRMANN, L. SOINNE, A. D. BARRETO, V. K. SHARMA, Robert MIKULÍK, K. W. MUIR, T. ROTHLISBERGER, J. C. GROTTA, C. R. LEVI, C. A. MOLINA, M. SAQQUR, L. PALAIODIMOU, T. PSALTOPOULOU, M. R. VOSKO, T. MOREIRA, J. B. FIEBACH, M. RUBIERA, E. C. SANDSET, A. DE HAVENON, T. A. KENT, A. W. ALEXANDROV, P. D. SCHELLINGER and G. TSIVGOULIS. Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis. European Journal of Neurology. Oxford: Rapid Science Ltd., 2020, vol. 27, No 12, p. 2453-2462. ISSN 1351-5101. Available from: https://dx.doi.org/10.1111/ene.14447.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis
Authors KATSANOS, A. H. (124 Canada), A. V. ALEXANDROV (840 United States of America), P. MANDAVA (840 United States of America), M. KOHRMANN (276 Germany), L. SOINNE (246 Finland), A. D. BARRETO (840 United States of America), V. K. SHARMA (702 Singapore), Robert MIKULÍK (203 Czech Republic, belonging to the institution), K. W. MUIR (826 United Kingdom of Great Britain and Northern Ireland), T. ROTHLISBERGER (840 United States of America), J. C. GROTTA (840 United States of America), C. R. LEVI (36 Australia), C. A. MOLINA (724 Spain), M. SAQQUR (124 Canada), L. PALAIODIMOU (300 Greece), T. PSALTOPOULOU (300 Greece), M. R. VOSKO (40 Austria), T. MOREIRA (752 Sweden), J. B. FIEBACH (276 Germany), M. RUBIERA (724 Spain), E. C. SANDSET (578 Norway), A. DE HAVENON (840 United States of America), T. A. KENT (840 United States of America), A. W. ALEXANDROV (840 United States of America), P. D. SCHELLINGER (276 Germany) and G. TSIVGOULIS (300 Greece, guarantor).
Edition European Journal of Neurology, Oxford, Rapid Science Ltd. 2020, 1351-5101.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.089
RIV identification code RIV/00216224:14110/20:00116375
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/ene.14447
UT WoS 000559990700001
Keywords in English blood pressure; intracranial hemorrhage; outcome; pulse pressure; sonothrombolysis; stroke; thrombolysis; variability
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 24/11/2020 12:24.
Abstract
Background and purpose Blood pressure (BP) variability has been associated with worse neurological outcomes in acute ischaemic stroke (AIS) patients receiving treatment with intravenous thrombolysis (IVT). However, no study to date has investigated whether pulse pressure (PP) variability may be a superior indicator of the total cardiovascular risk, as measured by clinical outcomes. Methods Pulse pressure variability was calculated from 24-h PP measurements following tissue plasminogen activator bolus in AIS patients enrolled in the Combined Lysis of Thrombus using Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization (CLOTBUST-ER) trial. The outcomes of interest were the pre-specified efficacy and safety end-points of CLOTBUST-ER. All associations were adjusted for potential confounders in multivariable regression models. Results Data from 674 participants was analyzed. PP variability was identified as the BP parameter with the most parsimonious fit in multivariable models of all outcomes, and was independently associated (P < 0.001) with lower likelihood of both 24-h neurological improvement and 90-day independent functional outcome. PP variability was also independently related to increased odds of any intracranial bleeding (P = 0.011) and 90-day mortality (P < 0.001). Every 5-mmHg increase in the 24-h PP variability was independently associated with a 36% decrease in the likelihood of 90-day independent functional outcome (adjusted odds ratio 0.64, 95% confidence interval 0.52-0.80) and a 60% increase in the odds of 90-day mortality (adjusted odds ratio 1.60, 95% confidence interval 1.23-2.07). PP variability was not associated with symptomatic intracranial bleeding at either 24 or 36 h after IVT administration. Conclusions Increased PP variability appears to be independently associated with adverse short-term and long-term functional outcomes of AIS patients treated with IVT.
PrintDisplayed: 9/5/2024 06:58